197 related articles for article (PubMed ID: 34310645)
1. The influence of LncRNA H19 polymorphic variants on susceptibility to cancer: A systematic review and updated meta-analysis of 28 case-control studies.
Wang K; Zhu Z; Wang Y; Zong D; Xue P; Gu J; Lu D; Tu C
PLoS One; 2021; 16(7):e0254943. PubMed ID: 34310645
[TBL] [Abstract][Full Text] [Related]
2. Association between lncRNA H19 polymorphisms and cancer susceptibility based on a meta-analysis from 25 studies.
Liu C; Chen L; You Z; Wu Y; Wang C; Zhang G; Xu B; Chen M
Gene; 2020 Mar; 729():144317. PubMed ID: 31884107
[TBL] [Abstract][Full Text] [Related]
3. Association between genetic polymorphisms of long noncoding RNA H19 and cancer risk: a meta-analysis.
Hashemi M; Moazeni-Roodi A; Sarabandi S; Karami S; Ghavami S
J Genet; 2019 Sep; 98():. PubMed ID: 31544800
[TBL] [Abstract][Full Text] [Related]
4. Association of lncRNA H19 polymorphisms with cancer susceptibility: An updated meta-analysis based on 53 studies.
Yuan Y; Wang Y; Niu X; Han Y; Li W; Cheng M; Li Z; Tan J; Zhao Y; Wang W
Front Genet; 2022; 13():1051766. PubMed ID: 36588790
[TBL] [Abstract][Full Text] [Related]
5. Significant association between long non-coding RNA H19 polymorphisms and cancer susceptibility: A PRISMA-compliant meta-analysis and bioinformatics prediction.
Li W; Jiang X; Jin X; Yan W; Liu Y; Li D; Zhao Z
Medicine (Baltimore); 2020 Apr; 99(15):e19322. PubMed ID: 32282694
[TBL] [Abstract][Full Text] [Related]
6. Significant association between lncRNA H19 polymorphisms and cancer susceptibility: a meta-analysis.
Li XF; Yin XH; Cai JW; Wang MJ; Zeng YQ; Li M; Niu YM; Shen M
Oncotarget; 2017 Jul; 8(28):45143-45153. PubMed ID: 28404885
[TBL] [Abstract][Full Text] [Related]
7. Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis.
Yang M; Zhang M; Wang Q; Guo X; Geng P; Gu J; Ji W; Zhang L
BMC Cancer; 2023 Jul; 23(1):688. PubMed ID: 37480014
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of polymorphisms in H19 lncRNA and cancer risk: a meta-analysis of 13,392 cases and 18,893 controls.
Chu M; Yuan W; Wu S; Wang Z; Mao L; Tian T; Lu Y; Zhu B; Yang Y; Wang B; Gao H; Jiang L; Zhuang X
Oncotarget; 2016 Nov; 7(48):78631-78639. PubMed ID: 27732938
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of lncRNA H19 polymorphisms and cancer risk: a meta-analysis based on 48,166 subjects.
Liu X; Zhao Y; Li Y; Zhang J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):15-27. PubMed ID: 31852249
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Long Noncoding RNA H19 Polymorphisms and Risk of Coronary Artery Disease in a Chinese Population: A Case-Control Study.
Hu WN; Ding HX; Xu Q; Zhang XY; Yang DT; Jin YZ
Dis Markers; 2020; 2020():9839612. PubMed ID: 32454910
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma.
Wang YC; Tsao SM; Li YT; Lee CY; Tsao TC; Hsieh MJ; Yang SF
Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33799753
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population.
Li S; Hua Y; Jin J; Wang H; Du M; Zhu L; Chu H; Zhang Z; Wang M
Oncotarget; 2016 May; 7(18):25470-7. PubMed ID: 27027436
[TBL] [Abstract][Full Text] [Related]
13. Association between long non-coding RNA H19 polymorphisms and breast cancer risk: a meta-analysis.
Li L; Huang Q; Yan F; Wei W; Li Z; Liu L; Deng J
Women Health; 2022 Jul; 62(6):565-575. PubMed ID: 35818166
[TBL] [Abstract][Full Text] [Related]
14. Association between lncRNA-H19 polymorphisms and hepatoblastoma risk in an ethic Chinese population.
Tan T; Li J; Wen Y; Zou Y; Yang J; Pan J; Hu C; Yao Y; Zhang J; Xin Y; Li S; Xia H; He J; Yang T
J Cell Mol Med; 2021 Jan; 25(2):742-750. PubMed ID: 33236528
[TBL] [Abstract][Full Text] [Related]
15. Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population.
Li Z; Niu Y
Minerva Urol Nefrol; 2019 Apr; 71(2):161-167. PubMed ID: 29595036
[TBL] [Abstract][Full Text] [Related]
16. Association of lncRNA H19 rs217727 polymorphism and cancer risk in the Chinese population: a meta-analysis.
Lu Y; Tan L; Shen N; Peng J; Wang C; Zhu Y; Wang X
Oncotarget; 2016 Sep; 7(37):59580-59588. PubMed ID: 27486980
[TBL] [Abstract][Full Text] [Related]
17. The association of polymorphisms in lncRNA-
Yang ML; Huang Z; Wang Q; Chen HH; Ma SN; Wu R; Cai WS
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29511035
[TBL] [Abstract][Full Text] [Related]
18. Associations between
Hu C; Yang T; Pan J; Zhang J; Yang J; He J; Zou Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30890582
[No Abstract] [Full Text] [Related]
19. H19 gene polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study.
Li W; Hua RX; Wang M; Zhang D; Zhu J; Zhang S; Yang Y; Cheng J; Zhou H; Zhang J; He J
Mol Genet Genomic Med; 2021 Feb; 9(2):e1584. PubMed ID: 33403826
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 polymorphisms associated with the risk of OSCC in Chinese population.
Guo QY; Wang H; Wang Y
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3770-3774. PubMed ID: 28975993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
